Neuropace Inc (NPCE)

Dec 11, 2025

NeuroPace (NASDAQ:NPCE) Price Target Raised to $20.00 at JPMorgan Chase & Co. - Defense World

Dec 11, 2025

Dec 10, 2025

NeuroPace price target raised to $20 from $18 at JPMorgan - TipRanks

Dec 10, 2025

Dec 10, 2025

JP Morgan Raises Price Target for NPCE to $20.00, Maintains Over - GuruFocus

Dec 10, 2025

Dec 10, 2025

JPMorgan Chase & Co. Issues Positive Forecast for NeuroPace (NASDAQ:NPCE) Stock Price - MarketBeat

Dec 10, 2025

Dec 09, 2025

NeuroPace stock rises on positive NAUTILUS trial results, UBS reiterates Buy - Investing.com UK

Dec 09, 2025

Dec 09, 2025

NeuroPace stock rises on positive NAUTILUS trial results, UBS reiterates Buy By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy - BioSpace

Dec 09, 2025

Dec 08, 2025

Neuropace shows 77% reduction in seizures - BioWorld MedTech

Dec 08, 2025

Dec 08, 2025

NeuroPace presents NAUTILUS trial data at American Epilepsy Society meeting - TipRanks

Dec 08, 2025

Dec 08, 2025

NeuroPace reports 77% seizure reduction in epilepsy device trial - Investing.com

Dec 08, 2025

Dec 08, 2025

NeuroPace reports 77% seizure reduction in epilepsy device trial By Investing.com - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Neuropace announces positive 18-month NAUTILUS trial results in idiopathic generalized epilepsy - marketscreener.com

Dec 08, 2025

Dec 08, 2025

NeuroPace, Inc. $NPCE Shares Acquired by Divisadero Street Capital Management LP - MarketBeat

Dec 08, 2025

Dec 07, 2025

Is NeuroPace Stock Built to Withstand a Pullback? - Trefis

Dec 07, 2025

Dec 06, 2025

MACD Signal: Will USCF ETF Trust USCF Sustainable stock attract long term capital inflowsJuly 2025 Analyst Calls & Reliable Intraday Trade Plans - BỘ NỘI VỤ

Dec 06, 2025

Dec 06, 2025

NeuroPace Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 06, 2025

Dec 06, 2025

Panagora Asset Management Inc. Makes New $1.11 Million Investment in NeuroPace, Inc. $NPCE - MarketBeat

Dec 06, 2025

Dec 05, 2025

Will NeuroPace Inc. stock deliver consistent dividendsEarnings Growth Summary & Reliable Price Breakout Signals - Newser

Dec 05, 2025

Dec 04, 2025

Published on: 2025-12-04 13:47:14 - Newser

Dec 04, 2025

Dec 04, 2025

Is NeuroPace Inc. stock ready for breakoutJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser

Dec 04, 2025

Dec 03, 2025

Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion - marketscreener.com

Dec 03, 2025

Dec 03, 2025

NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting - BioSpace

Dec 03, 2025

Dec 02, 2025

NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society Annual Meeting - Investing News Network

Dec 02, 2025

Dec 02, 2025

Why analysts remain bullish on NeuroPace Inc. stockM&A Rumor & Technical Entry and Exit Alerts - Newser

Dec 02, 2025

Nov 29, 2025

NeuroPace (NASDAQ:NPCE) Trading Down 4.1%Should You Sell? - MarketBeat

Nov 29, 2025

Nov 29, 2025

NeuroPace announces Medicare reimbursement increases for RNS System - MSN

Nov 29, 2025

Nov 28, 2025

NeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 28, 2025

Nov 27, 2025

Why NeuroPace, Inc. (NASDAQ:NPCE) Could Be Worth Watching - 富途牛牛

Nov 27, 2025

Nov 27, 2025

NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 27, 2025

Nov 24, 2025

NeuroPace NPCE insider updates holdings after RSU tax withholding - Stock Titan

Nov 24, 2025

Nov 24, 2025

Medicare boosts reimbursement for NeuroPace’s epilepsy treatment system By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services - Investing News Network

Nov 24, 2025

Nov 24, 2025

Medicare boosts reimbursement for NeuroPace’s epilepsy treatment system - Investing.com

Nov 24, 2025

Nov 24, 2025

NeuroPace jumps as Medicare boosts pay for epilepsy device procedures - TradingView

Nov 24, 2025

Nov 24, 2025

NeuroPace Says Medicare Increases Reimbursement for RNS Procedures - marketscreener.com

Nov 24, 2025

Nov 22, 2025

NeuroPace Inc Stock Analysis and ForecastVolatility Index Analysis & Access High Yield Alerts - earlytimes.in

Nov 22, 2025

Nov 21, 2025

Can NeuroPace Inc. stock deliver strong Q4 earningsMarket Growth Summary & Real-Time Sentiment Analysis - newser.com

Nov 21, 2025

Nov 21, 2025

Is NeuroPace Inc. stock gaining market shareBond Market & Consistent Profit Trade Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Why NeuroPace Inc. stock could rally in 2025July 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 21, 2025

Nov 20, 2025

Why NeuroPace Inc. stock remains on buy listsMarket Risk Analysis & AI Driven Price Predictions - newser.com

Nov 20, 2025

Nov 20, 2025

3 Stocks Possibly Trading At A Discount Of Up To 37.8% - Sahm

Nov 20, 2025

Nov 20, 2025

How rising interest rates impact NeuroPace Inc. stockTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com

Nov 20, 2025

Nov 20, 2025

NeuroPace, Inc. Reports Record Revenue and Strong Margins in Q2 2025 Earnings Call - MSN

Nov 20, 2025

Nov 19, 2025

Neuropace, Inc. Advances in Treating Lennox-Gastaut Syndrome: A Study Update - MSN

Nov 19, 2025

Nov 19, 2025

How to escape a deep drawdown in NeuroPace Inc.Global Markets & Daily Chart Pattern Signal Reports - newser.com

Nov 19, 2025